Previous 10 | Next 10 |
2023-07-29 09:55:43 ET Summary Danaher Corporation reported solid Q2 2023 earnings with revenue of $7.16B (7.6% YoY decline) and EPS of $2.05 (25.7% YoY decline). The company's Danaher Business System (DBS) helped navigate challenges, maintaining revenue, earnings, and cash flow e...
2023-07-27 18:04:31 ET Summary GE HealthCare Technologies' revenue growth is expected to benefit from price increases, healthy end-market demand, and increasing digitization in healthcare. The company reported better-than-expected Q2 2023 earnings, with revenue increasing by 9.1% ...
Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC PR Newswire ANAHEIM, Calif. , July 25, 2023 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today revea...
Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance PR Newswire ANAHEIM, Calif. , July 25, 2023 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, received F...
2023-07-25 10:43:07 ET Danaher Corporation (DHR) Q2 2023 Earnings Conference Call July 25, 2023, 08:00 AM ET Company Participants John Bedford - VP, IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Conference Call Participants Michael Rys...
2023-07-25 08:22:48 ET NeuroOne Medical Technologies Corporation ( NMTC ) -35% . announces pricing of public offering of common stock . Stoke Therapeutics ( STOK ) -34% announces positive new safety & efficacy data from patients treated with STK-001 in the ...
2023-07-25 07:30:47 ET Despite posting better than expected financials for Q2 2023, Danaher Corporation ( NYSE: DHR ) slipped ~5% pre-market Tuesday as the U.S. life sciences company lowered its full-year outlook amid falling COVID-related revenue. Danaher’s ( DHR ...
2023-07-25 06:01:38 ET Danaher press release ( NYSE: DHR ): Q2 Non-GAAP EPS of $2.05 beats by $0.03 . Revenue of $7.16B (-7.6% Y/Y) beats by $40M . Revenues decreased 7.5% year-over-year to $7.2 billion, with a 7.0% non-GAAP core revenue decrease (due primarily...
Danaher Reports Second Quarter 2023 Results PR Newswire WASHINGTON , July 25, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the second quarter 2023. Net earnings refer to net earnings attributable to c...
2023-07-25 03:48:12 ET Summary Danaher is an industry-leading serial acquirer with an iconic business system. After a boom in Danaher's sales during the pandemic, demand is now slowing as customers are facing inventory build-up and liquidity challenges. Beyond the current head...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...